Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Oxalyl chloride → N3-(5-Chlorothiophen-2-ylcarbonyl)-N2-[1-(4-pyridyl)piperidin-4-ylmethyl]-2,3-pyridinediamine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Oxalyl chloride | HCID 65578 | — |
| 반응물 | 5-Chloro-2-thiophenecarboxylic acid | HCID 95048 | — |
| 반응물 | N2-[1-(4-pyridyl)piperidin-4-ylmethyl]-2,3-pyridinediamine | HCID 12150690 | — |
| 용매 | Pyridine | HCID 1049 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | N3-(5-Chlorothiophen-2-ylcarbonyl)-N2-[1-(4-pyridyl)piperidin-4-ylmethyl]-2,3-pyridinediamine | HCID 12990572 | 62.3% |
반응 단계
A solution of 5-chlorothiophene-2-carboxylic acid (120 mg, 0.72 mmol) in methylene chloride and DMF (0.005 mL) was treated with oxalyl chloride (0.105 mL, 1.20 mmol). After 0.25 h, the mixture was concentrated and the residue was dissolved in chloroform. This solution was added dropwise to a solution of N2-[1-(4-pyridyl)piperidin-4-ylmethyl]-2,3-pyridinediamine (170 mg, 0.6 mmol) in pyridine and chloroform. The reaction mixture was then purified using a procedure similar to that described in Example 2, Part D, yielding 160 mg (58%) of the title compound as a hydrochloride salt.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06710057B2 |
| 출처 데이터셋 | uspto-grants-2004_03 |
| ORD ID | ord-0208a0524ee5473484eeef0ced84e59f |
| 출처 메모 | uspto-grants-2004_03 |